Patents by Inventor Klaus Fuchs

Klaus Fuchs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines
    Publication number: 20020042410
    Abstract: Compounds of formula 1, 1
    Type: Application
    Filed: July 24, 2001
    Publication date: April 11, 2002
    Inventors: Klaus Fuchs, Werner Stransky, Matthias Grauert, Adrian Carter, Wolfram Gaida, Thomas Weiser, Helmut Ensinger
  • Beta-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
    Publication number: 20020042420
    Abstract: Compounds of general formula (I) 1
    Type: Application
    Filed: July 24, 2001
    Publication date: April 11, 2002
    Inventors: Hans Briem, Klaus Mendla, Helmut Michael Romig, Katja Fechteler, Klaus Fuchs
  • Process for finding a protease inhibitor
    Publication number: 20020025508
    Abstract: The present invention relates to a process for finding substances capable of specifically inhibiting membrane-bound proteases and a high throughput screening test for finding substances capable of specifically inhibiting &ggr;-secretase or presenilinase. The invention further relates to the use of this process or this high throughput screening test for finding substances which are specifically capable of inhibiting &ggr;-secretase or presenilinase. It also discloses substances which can be found with a process according to the invention, the use of said substances according to the invention for preparing a medicament for treating neurodegenerative disorders, particularly Alzheimer's disease, and pharmaceutical formulations containing the substances according to the invention.
    Type: Application
    Filed: January 5, 2001
    Publication date: February 28, 2002
    Inventors: Katja Fechteler, Marcus Kostka, Klaus Fuchs, Christian Haass, Harald Steiner
  • Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
    Patent number: 6136527
    Abstract: The cloning and sequencing of different polypeptides from the genome of a hepatitis C virus is disclosed. The polypeptides are prepared as non-fusion proteins in good yield. The polypeptide originating from the structure protein (core) is soluble under physiological conditions. Since the polypeptides have no foreign protein portions, they are preferably used in test kits and as vaccine.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: October 24, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Klaus Fuchs, Manfred Motz, Michael Roggendorf, Erwin Soutschek